CLINICAL_TRIALS
trial_result
· 2016-04-11
Clinical Trial Update: Premenopausal Endocrine Responsive Chemotherapy Trial [Phase 3]
Summary
A Phase 3 trial of a premenopausal endocrine-responsive chemotherapy regimen for breast cancer was terminated; results were posted on 2016-04-11.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2016-04-11